The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. - Wikidata - awgldk - TriplyDB

The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis.

The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis.

http://www.wikidata.org/entity/Q36120942

about

The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment Neutrophil to Lymphocyte Ratio (NLR) at the Time of Transurethral Resection of Bladder Tumor: A Large Retrospective Study and Analysis of Racial Differences.The utility of the preoperative neutrophil-to-lymphocyte ratio in predicting severe cholecystitis: a retrospective cohort study.Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease.The Pretreatment Neutrophil/Lymphocyte Ratio Is Associated with All-Cause Mortality in Black and White Patients with Non-metastatic Breast Cancer.Neutrophil to lymphocyte ratio may predict mortality in breast cancer patients.Significant decline in anticancer immune capacity during puberty in the Tasmanian devil.Can Neutrophil/Lymphocyte Ratio be a Predictor for Bone Metastases of Solid Tumors?Predicting outcome after percutaneous balloon mitral commissurotomy : Role of neutrophil-lymphocyte ratio.Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients.

P2860

Q28241308-1A74CB37-3F3D-487C-8238-0879D0F2A5EE Q33614530-009D0E9F-B396-4332-820D-2B9B016E77FC Q34794460-6785481F-943C-4D86-9A14-CAD2959694D3 Q34899176-D921E59D-A15A-4029-AA3A-540E8F5F21DA Q36749454-3CB2F8C2-244F-49ED-9E9D-9362146AEB86 Q37240079-E26EE769-B7BA-46D8-B72B-022BEE58ACB4 Q37704509-ACF1635D-E3C5-477E-A8D0-FADF988EE7A1 Q47109054-EAFC1C94-851C-4DB1-B9F0-FFC10B8FE1F3 Q47646612-4FE81B6D-197A-4495-8DE4-CB4F7D13C3AC Q52602665-A2A31BB5-D11E-4FF6-B277-9CDB714F71AD

P2860

The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis.

http://www.wikidata.org/entity/Q36120942

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

The neutrophil/lymphocyte rati ...... patients with bone metastasis.

@ast

The neutrophil/lymphocyte rati ...... patients with bone metastasis.

@en

type

label

The neutrophil/lymphocyte rati ...... patients with bone metastasis.

@ast

The neutrophil/lymphocyte rati ...... patients with bone metastasis.

@en

prefLabel

The neutrophil/lymphocyte rati ...... patients with bone metastasis.

@ast

The neutrophil/lymphocyte rati ...... patients with bone metastasis.

@en

P1433

Q36120942-1658D7D2-D138-4305-A1CB-4BC982220381

P1476

Q36120942-7F7F71A0-B0A1-4464-9A6E-68BBBD5953E1

P2093

Q36120942-3A670975-A8BD-4587-B03E-1904C4E032CB

Q36120942-4841D063-1710-48C9-8E1E-04870899D17B

Q36120942-4F90DEF2-A2A5-4003-9818-BA0F1D0F8703

Q36120942-BF72A59C-6324-4691-A545-7C1E5AD41712

Q36120942-CCD5893B-1006-41AD-BE64-FE1A6F9C49F7

Q36120942-F7BBACBD-A6DF-4951-A442-4C026E5B1CEA

P2860

Q36120942-08F8B55C-EDC5-4B7F-8A20-298774410F94

Q36120942-1488E6D7-825D-49F3-8850-CA6ADDB7A4C2

Q36120942-2D68DF84-C65D-470A-BC30-32C5DD785312

Q36120942-4D7FD762-A1AC-4694-8E60-EFA33EE85291

Q36120942-5AB9BC7F-FC9F-4AEF-95E2-44B7E8D346EA

Q36120942-5DE69A55-642B-4ACE-B570-BC0A55879536

Q36120942-8D9A8326-0B35-4ED9-89A1-2D50F1E83EBD

Q36120942-9EEBB346-7CA4-48B9-A1CB-1C69E913F6A9

Q36120942-AFB575B5-362D-4F14-BE0A-CB7407FFF3F0

Q36120942-DD8391B5-BC55-4ECD-BFAC-249C80ED6F8B

P304

Q36120942-5FEBFBB2-906E-4F54-AFC4-15F7D848D410

P31

Q36120942-EC153149-FAFB-4AFC-893C-654231E5D25F

P356

Q36120942-72B92A7A-618C-47FF-B09E-287FDAA0F23B

P433

Q36120942-B8DE0446-6E49-4EAB-814A-3C2798C291DF

P478

Q36120942-197D5C0B-AD4D-4C3A-9E02-005DA796C4E6

P577

Q36120942-4258D5E6-AD01-422B-8FF7-FF0E33E413AE

P5875

Q36120942-F3DD0154-54F4-4446-8FDC-A59EF820384F

P698

Q36120942-C267FFE7-7269-4923-9043-FC8652434818

P932

Q36120942-81C310DB-F2B3-4406-A215-118119112604

P356

P1433

Oncology Letters

P1476

The neutrophil/lymphocyte rati ...... patients with bone metastasis.

@en

P2093

Fengqi Fang

http://www.w3.org/2001/XMLSchema#string

Huanran Liu

http://www.w3.org/2001/XMLSchema#string

Shouyu Wang

http://www.w3.org/2001/XMLSchema#string

Wei Sun

http://www.w3.org/2001/XMLSchema#string

Xue Gao

http://www.w3.org/2001/XMLSchema#string

Zhen Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Metastasis to bone: causes, consequences and therapeutic opportunities

The microenvironment of the tumour-host interface

Neutrophils in the antitumoral immune response.

The clinical course of bone metastases from breast cancer.

Metastatic renal carcinoma comprehensive prognostic system

Cancer statistics, 1995.

Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis.

Impact of immune parameters on long-term survival in metastatic renal cell carcinoma.

The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer.

P304

735-740

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2011.304

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230589873

http://www.w3.org/2001/XMLSchema#string

P698

22848258

http://www.w3.org/2001/XMLSchema#string

P932

3406337

http://www.w3.org/2001/XMLSchema#string